| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 08/16/2007 | DE102006057250A1 Benzochromenderivate Benzochromene derivatives |
| 08/16/2007 | DE102005061428A1 Substituierte Cyclohexylmethyl-Derivate Cyclohexylmethyl substituted derivatives |
| 08/16/2007 | CA2641685A1 3-heteroaryl-3,9-diazabicyclo[3.3.1]nonane derivatives as nicotinic acetylcholine receptor agonists |
| 08/16/2007 | CA2641678A1 3,9-diazabicyclo[3.3.1]nonane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 08/16/2007 | CA2641665A1 Modified release formulation |
| 08/16/2007 | CA2641632A1 Novel spiro[imidazolidine-4,3'-indole]-2,2',5(1'h)-triones for treatment of conditions associated with vanilloid receptor 1 |
| 08/16/2007 | CA2641555A1 Preferential inhibition of presenilin-1 |
| 08/16/2007 | CA2641453A1 Thiadiazole derivatives for the treatment of neuro degenerative diseases |
| 08/16/2007 | CA2641396A1 Process for manufacturing entacapone |
| 08/16/2007 | CA2641070A1 Enzyme replacement therapy for treating lysosomal storage diseases |
| 08/16/2007 | CA2640470A1 Non-natural amino acid derivatives |
| 08/16/2007 | CA2640469A1 Amino acid derivatives |
| 08/16/2007 | CA2637792A1 Combination of organic compounds |
| 08/16/2007 | CA2637292A1 Use of 2-imidazoles for the treatment of cns disorders |
| 08/15/2007 | EP1818395A1 Compositions and methods for treating lysosomal storage diseases |
| 08/15/2007 | EP1818343A2 Antibodies against human IL-12 |
| 08/15/2007 | EP1818325A2 3,4-DI-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands |
| 08/15/2007 | EP1818063A1 Medicine for treatment of disease caused by hyperstimulatory cytotoxicity and therapeutic method |
| 08/15/2007 | EP1818051A1 Microgranules of morphine sulphate, preparation method and composition containing them |
| 08/15/2007 | EP1817328A2 New peptides useful as dual caspase-2/-6 inhibitors and their biological applications |
| 08/15/2007 | EP1817312A1 Macrocyclic aminopyridyl beta-secretase inhibitors for the treatment of alzheimer's disease |
| 08/15/2007 | EP1817311A2 2,3,4,6-substituted pyridyl derivative compounds useful as beta-secretase inhibitors for the treatment of alzheimer's disease |
| 08/15/2007 | EP1817301A1 Potentiators of glutamate receptors |
| 08/15/2007 | EP1817300A1 Potentiators of glutamate receptors |
| 08/15/2007 | EP1817296A1 Potentiators of glutamate receptors |
| 08/15/2007 | EP1817286A1 Donepezil salts suitable for the preparation of pharmaceutical compositions |
| 08/15/2007 | EP1817039A2 Treatment and prevention of epilepsy |
| 08/15/2007 | EP1817037A1 Triazole compounds suitable for treating disorders that respond to modulaiont of the dopamine d3 receptor |
| 08/15/2007 | EP1817036A2 Modulators of muscarinic receptors |
| 08/15/2007 | EP1817032A2 Modulators of muscarinic receptors |
| 08/15/2007 | EP1817029A1 Isoxazolic derivative to relieve neuropathic pain |
| 08/15/2007 | EP1817014A1 Method of providing fast relief to a user of a nicotine chewing gum |
| 08/15/2007 | EP1817011A2 Methods and compositions for deterring abuse of orally administered pharmaceutical products |
| 08/15/2007 | EP1816912A2 Treatment of stroke with histamine h3 inverse agonists or histamine h3 antagonists |
| 08/15/2007 | EP1697305B1 Substituted (4-aminocyclohexen-1-yl)phenyl and (4-aminocyclohexen-1-yl)pyridinyl compounds as 5-ht1f agonists |
| 08/15/2007 | EP1677791A4 Nitrogen-containing fused heterocyclic compounds |
| 08/15/2007 | EP1673092B1 Heterocycle-substituted pteridine derivatives and their use in therapy |
| 08/15/2007 | EP1663244B1 Pteridine derivatives for the treatment of tnf-alpha-related diseases. |
| 08/15/2007 | EP1658292B1 Triazolopyrimidine derivatives as glycogen synthase kinase 3 inhibitors |
| 08/15/2007 | EP1646620B1 Substituted piperidines as histamine h3 receptor ligands |
| 08/15/2007 | EP1554280B1 Antidiabetic beta-amino heterocyclic dipeptidyl peptidase inhibitors |
| 08/15/2007 | EP1496904B1 Use of pharmaceuticals containing n, n'-disubstituted piperazine compounds |
| 08/15/2007 | EP1496059B1 Fused bicyclic pyrimidine derivatives |
| 08/15/2007 | EP1471886B1 Method for increasing the water-solubility of lipophilic, active substances, production of highly concentrated aqueous compositions of said active substances, corresponding products and their use |
| 08/15/2007 | EP1442023B1 Crystalline sodium salt of telmisartan and the use of the same as an angiotensin antagonist |
| 08/15/2007 | EP1385825B1 Substituted 2-pyridine-cyclohexane-1,4-diamine derivatives |
| 08/15/2007 | EP1377590B1 Thiazolopyrimidine derivatives and use thereof as antagonists of the cx3cr1 receptor |
| 08/15/2007 | EP1343488B1 Treatment of statin side effects |
| 08/15/2007 | EP1339458B1 Combination comprising an agent decreasing vegf activity and an agent decreasing egf activity |
| 08/15/2007 | EP1322596B1 Zwitterionic tachykinin receptor antagonists |
| 08/15/2007 | EP1292568B1 Benzamide ligands for the thyroid receptor |
| 08/15/2007 | EP1272614B1 Differentiation of bone marrow cells into neuronal cells and uses therefor |
| 08/15/2007 | EP1254251B1 Neurosteroids as markers for alzheimer's disease |
| 08/15/2007 | EP1196174B1 Dietary calcium as a supplement to vitamin d compound treatment of multiple sclerosis |
| 08/15/2007 | EP1192149B1 1,4-dithiin and 1,4-dithiepin- 1,1,4,4, tetroxide derivatives useful as antagonists of the human galanin receptor |
| 08/15/2007 | EP1189606B1 Novel iron chelators and pharmaceutical compositions comprising iron chelators for the treatment of neurodegenerative disorders |
| 08/15/2007 | EP1073432B1 Use of d-serine or d-alanine for treating schizophrenia |
| 08/15/2007 | EP0869975B1 Assay for and uses of peptide hormone receptor ligands |
| 08/15/2007 | CN1331865C Polymorphs and compositions and methods related thereto |
| 08/15/2007 | CN1331864C Novel 2,5-diazabicyclo [2.2.1] heptane derivatives |
| 08/15/2007 | CN1331853C Small molecule inhibitors of rotamase enzyme activity |
| 08/15/2007 | CN1331848C Tricyclic steroid hormone nuclear receptor modulators |
| 08/15/2007 | CN1331532C Botulinum toxin pharmaceutical compositions |
| 08/15/2007 | CN1331481C Method for extracting medicinal and edible substance from dictyoptera |
| 08/15/2007 | CN1331472C Quetiapingranulater |
| 08/15/2007 | CN101018799A Composition and method for inhibiting platelet aggregation |
| 08/15/2007 | CN101018779A Triazole compounds and their use as metabotropic glutamate receptor antagonists |
| 08/15/2007 | CN101018778A Substituted oxindol derivatives and medicaments containing the same |
| 08/15/2007 | CN101018769A Dimeric piperidine derivates |
| 08/15/2007 | CN101018762A Novel derivatives of 3, 5-seco-4-norcholestane and use thereof |
| 08/15/2007 | CN101018546A (halobenzyloxy) benzylamino-propanamides as sodium and/or calcium channel selective modulators |
| 08/15/2007 | CN101016296A Muscarinic agonists |
| 08/15/2007 | CN101015698A Medicament using rare earth transferring complex compound as vector |
| 08/15/2007 | CN101015692A Molecular antigen array |
| 08/15/2007 | CN101015665A Medicine composition with sleeping improving function, preparing process and quality controlling means thereof |
| 08/15/2007 | CN101015656A Method for preparation of pure gastrodia elata capsule with sleeping improving and hypoxia resistant functions |
| 08/15/2007 | CN101015655A Children's anti-epilepsy agent |
| 08/15/2007 | CN101015654A Oral traditional Chinese medicine preparation for treating depression and dysphoria |
| 08/15/2007 | CN101015652A Health-care medicated wine for person in middle and old age |
| 08/15/2007 | CN101015648A Use of succinic acid derivative eater compound for treating dementia |
| 08/15/2007 | CN101015642A Compound capsule for decreasing alcohol and protecting liver |
| 08/15/2007 | CN101015618A Health-care wine with sleeping improving and beauty functions and its preparing process |
| 08/15/2007 | CN101015610A Medicine for curing cerebral concussion |
| 08/15/2007 | CN101015605A Health-care food for improving sleeping and its preparing process |
| 08/15/2007 | CN101015575A Process for preparing bupleurum root dropping pills |
| 08/15/2007 | CN101015552A Ligustilide extract and its preparing process and application |
| 08/15/2007 | CN101015543A Use of cinnamic acid and allyl benzoate compound with oxidation resistance function for protecting liver and brain damage |
| 08/15/2007 | CN101015381A Drink for dispelling effects of liquor and protecting liver and its preparation method |
| 08/14/2007 | US7256288 For therapy or prophylaxis of diseases and for improving perception, concentration, learning and/or memory |
| 08/14/2007 | US7256217 Prodrugs of excitatory amino acids |
| 08/14/2007 | US7256216 Powder mixture of aminobutyric acid and solid polyol; therapy for brain disorders; central nervous system disorders; analgesics; headaches |
| 08/14/2007 | US7256201 Selective estrogen receptor-β ligands |
| 08/14/2007 | US7256200 administering mixture of opioid and calmodulin kinase inhbitor |
| 08/14/2007 | US7256199 2-(Substituted amino)-6-(4-pyridyl)pyrimidin-4-ones, e.g., 2-(N-phenylamino)-6-(4-pyridyl)pyrimidin-4-one and 2-(N-(3-bromophenyl)amino)-6-(4-pyridyl)pyrimidin-4-one; treatment of diseases caused by tau protein kinase 1 hyperactivity such as Alzheimer disease. |
| 08/14/2007 | US7256195 Preparation of risperidone |
| 08/14/2007 | US7256193 Therapeutic agents useful for treating pain |
| 08/14/2007 | US7256184 analyzing concentration of carbonic anhydrase isozymes in tissues, blood or cerebrospinal fluid of patients, than administering proenzymes or drugs that promotes the natural generation of the cell-specific carbonic anhydrase enzymes; aging resistance |
| 08/14/2007 | US7256028 Methods for screening compounds that modulate lipid metabolism |
| 08/14/2007 | US7255882 Enkephalinase inhibitor and GABA precursor loading as anti-anxiety compositions |
| 08/14/2007 | US7255879 Extracting and recovering embryonic-like stem cells, including pluripotent or multipotent stem cells, from an exsanguinated human placenta; use of the isolated and perfused placenta as a bioreactor in which to propagate endogenous/exogenous cells |